Flatley Named Executive Chairman of Illumina as deSouza Steps Up to CEO Role | GenomeWeb
Illumina Appoints Marc Stapley as Senior Vice President and Chief Financial Officer
Marc Stapley - CEO at Veracyte | The Org
1 Huge Reason to Buy Illumina, Inc. Stock Now | The Motley Fool
Marc Stapley — Chief Administrative Officer and Executive Vice President at Illumina | Comparably
With new CEO, Veracyte outlines €260M deal for French test maker HalioDx and global cancer testing expansion | Fierce Biotech
Illumina Executive Team | Comparably
Pharma startup names veteran exec to board – TechCentury
Illumina Appoints Marc Stapley as Senior Vice President and Chief Financial Officer
Illumina Appoints Marc Stapley as Senior Vice President and Chief Financial Officer
Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Test Availability | Clinical Lab Products
StockWatch: Investors, Analysts Debate Background of New Illumina CEO
n2779_x119-img003.jpg
Veracyte Announces In Vitro Diagnostic Agreement With Illumina | Technology Networks
OncoCell MDx Appoints Marc Stapley to its Board of Directors | Business Wire
Veracyte and Illumina partner to develop IVD tests
n2779_x119-img002.jpg
Marc Stapley Net Worth (2023) - GuruFocus.com
How could the STAMPEDE trial shape prostate cancer care? - Oncology Central
Helix Expands Focus to Population Health Solutions and Appoints Illumina Veteran Marc Stapley as CEO
StockWatch: Investors, Analysts Debate Background of New Illumina CEO
Marc Stapley - CEO at Veracyte | The Org
Illumina: Unidentified Financing Operation? - by Mike
Illumina CFO Marc Stapley: Learn the Business Inside and Out - WSJ
Marc Stapley - Veracyte
